Latest news
CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong - TradingViewTradingView · Fri, 07 Aug 2026 18:22:00 GMTLexicon Pharmaceuticals Reports Q2 2026 Results; Completes Enrollment in Phase 3 SONATA-HCM Study and Advances ZYNQUISTA NDA Resubmission - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:44:00 GMTLexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM) - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTLexicon's HCM study spans 20 countries; results anticipated Q1 2027 - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT